Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PATH | Common Stock | Options Exercise | $67.8K | +13.4K | $5.06 | 13.4K | Nov 4, 2021 | Direct | ||
transaction | PATH | Common Stock | Sale | -$760K | -13.4K | -100% | $56.68 | 0 | Nov 4, 2021 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PATH | Stock Option (Right to Buy) | Options Exercise | $0 | -13.4K | -4.18% | $0.00 | 307K | Nov 4, 2021 | Common Stock | 13.4K | $5.06 | Direct | F3 |
Id | Content |
---|---|
F1 | These shares were sold in compliance with a qualified selling plan adopted by the reporting person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. |
F2 | The range of prices for the transactions reported were from $56.0900 to $57.2100. The reporting person will provide, upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. |
F3 | 25% of the shares underlying this stock option vested on April 15, 2020, with the remaining 75% vesting in 36 equal monthly installments. |